AMEH - ApolloMed Market Capitalization-to-Revenue Ratio

Symbol and logo of brand ApolloMed (AMEH)

Operations in the US protect the business from direct conflicts, although drug inflation remains a risk. The smoothed P/S of Apollo Medical Holdings demonstrates the dynamics of this influence, where the 0.40 mark records this metric. Despite pressure from insurance behemoths, an impeccable reputation in the value-based healthcare segment guarantees Apollo Medical Holdings sustainable leadership and the trust of clinics.

AMEH Apollo Medical Holdings: P/S Multiple in the range 07/04/2022 - 11/14/2026

Analytical breakdowns for Apollo Medical Holdings (AMEH)

- current quotes and average value forecast:
- market capitalization statistics:
General company analysis:AMEH (Apollo Medical Holdings Inc.)
Manufactured products of Apollo Medical Holdings Inc.

The price-to-sales ratio dynamics for Apollo Medical Holdings (AMEH) reflect the market value of one dollar of revenue amid stringent HIPAA and Medicare regulations. This indicator is calculated by dividing the business's market capitalization by total turnover, allowing investors to strip away accounting distortions and assess the actual premium for the IT platform's technological dominance in the risk management sector.

Competing companies

VEEV - Price to Sales|Doximity - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio HQY|WAY - Price-to-Revenue Ratio|CorVel Corp. (CRVL) - Market Cap to Revenue|PRVA: P/S Multiple|Price to Sales huronconsultinggroup.com (HURN)|CERT (Certara) - P/S Multiple|Market Cap to Revenue Ratio OMCL (Omnicell Inc)|P/S Multiple GDRX|Price-to-Revenue Coefficient Schrodinger Corp|P/S Multiple PHR (Phreesia, Inc.)|OMDA - Market Cap to Revenue|Evolent Health - P/S Multiple|HSTM - P/S Multiple|Definitive Healthcare Inc. (DH) - Price-to-Revenue Ratio|CCSI (Consensus Corp) - Price-to-Revenue Ratio|Market Cap to Revenue AGL|ABSI: Market Capitalization-to-Revenue Ratio|P/S Multiple SY|NRC (NRC Health) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Spok Corp SPOK|OptimizeRx Inc. (OPRX) - Price to Sales|TBRG - Price-to-Revenue Ratio|SLP: Price-to-Revenue Ratio|SOPH: P/S Multiple|Market Cap to Revenue Ratio HCAT|CCLD (CareCloud Inc.) - P/S Multiple|Research Solutions Inc. (RSSS) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio DLH Holdings Corp. (DLHC)|onemednet.com - Market Cap to Revenue Ratio|P/S Multiple SCNX (Scienture)|Price-to-Revenue Multiple Healthcare Triangle Inc|ISPC - Price-to-Revenue Ratio|Price-to-Revenue Coefficient Bullfrog AI Holdings BFRG|WORX: P/S Multiple|msprecovery.com (MSPR) - P/S Multiple|Price-to-Revenue Ratio iCoreConnect, Inc.|Market Cap to Revenue TRxADE HEALTH Inc (MEDS)|P/S Multiple ORGS|RCM - Price to Sales|P/S Multiple SHCR (Sharecare, Inc.)|Market Capitalization-to-Revenue Ratio STRM|Syra Health - P/S Multiple|Price-to-Revenue Coefficient Model N Inc MODN|NXGN (NextGen) - Market Cap to Revenue